Brandon Smith
Partner at Childers, Schlueter & Smith, LLC
I’m M. Brandon Smith, a partner at Childers, Schlueter & Smith in Atlanta, Georgia, helping injured people nationwide with pharmaceutical litigation, mass torts, product liability, and serious personal injury cases.
Posts
-
Valsartan Medication May Be Causing Drug-Induced Angioedema
In July, the Food and Drug Administration (FDA) issued a voluntary recall of multiple medications containing valsartan that were manufactured by the Chinese pharmaceutical company, Zhejiang Huahai. The recall occurred after two likely carcinogenic chemicals, N-nitrosodimethylamine (NDMA) and N-Nitr
-
Valsartan Recalled After Testing Positive for Potentially Cancer-Causing Chemicals
Beginning in July, the U.S. Food and Drug Administration (FDA) has issued a series of recalls for multiple medications that contain the drug valsartan after two likely carcinogenic chemicals were found in valsartan batches that had been imported to the United States from China. Often…
-
Hernia Mesh Complications Can Also Cause Mental and Emotional Issues
Today, hernia mesh manufacturers such as Johnson & Johnson, Atrium, Covidien, and C.R. Bard, Inc., are the target of thousands of lawsuits because of medical complications that occurred after hernia mesh implant surgery. These infections can include extreme pain, infection, recurrence of hernia, org
-
Big Pradaxa Verdict in Favor of Plaintiffs: $1,250,000
We are happy to report a jury in West Virginia just returned a $250,000 compensatory award to our deserving clients. The same jury awarded $1,000,000 more in punitives to punish Boehringer Ingelheim for their wanton and willful acts in handling its blood thinner Pradaxa. Led…
-
FDA Seeks to Prevent Pharmaceutical Companies from Abusing ‘Orphan Drug’ Law
Recently, I discussed a couple of reports that have come to light, potentially exposing the shortcomings of an FDA policy on “fast tracking” the approval of certain new drugs. Now, the FDA is in the middle of a large operation to remedy other policy issues…
-
Could the FDA Be Approving Drugs Based on Questionable Evidence?
Every time you turn on the television, you are most likely bombarded by a barrage of advertisements for prescription drugs. While you might be wary of marketer’s claims and promises as to their effect, you can at least rest assured that all have passed stringent…
-
‘My Skin Was Melting’: One Woman’s Horror Story and the Generic Prescription Drug for Lamictal that Caused It.
In 2014, A young woman in Snellville, Georgia visited her doctor with claims of depression. Her physician prescribed lamotrigine, also marketed under the tradename Lamictal, a mood-stabilizing anticonvulsant best known for controlling seizures with those who suffer from epilepsy. While the medicatio
-
Ovarian Cancer Victim Awarded Over $70 Million In Third Jury Trial Over Talcum Powder
In the third consecutive talcum powder trial, a St. Louis City jury award plaintiff Deborah Giannecchini $2.57 million in compensatory damages and 67.5 million in punitive damages against Johnson & Johnson and the Imerys Talc America defendants for their talc-containing personal hygiene product. Per
-
Invokana and Farxiga Increase Warnings Over Acute Kidney Failure
The FDA just released more information on Invokana and Farxiga related to acute kidney failure. A topic and drug Childers, Schlueter & Smith have been investigating for a long time now. Check out our: Top 10 Things Invokana Patients Need To Know… As…
-
Canadian Invokana Lawsuit Seeks $1 Billion in Damages
An Invokana lawsuit filed last year in Canada seeks $1 billion in damages against drug maker Janssen Pharmaceuticals. The lawsuit, filed in September 2015 at the Ontario Superior Court of Justice, seeks class-action status, which is expected to be determined within the next six or…
Subscribe to Brandon Smith
Get new posts delivered to your inbox.